IMYSF (Imerys) Marketable Securities: $441 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMYSF Imerys IMYSF
59 GF Score
Price $24.72
GF Value $31.72
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Imerys Marketable Securities?

Imerys IMYSF +3.41% 59 Marketable Securities is $441 Mil as of Dec. 2025. GuruFocus rates IMYSF with a GF Score™ of 59/100 and a GF Value™ of $31.72 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Imerys's Marketable Securities for the quarter that ended in Dec. 2025 was $441 Mil.

Imerys's annual Marketable Securities declined from Dec. 2023 ($735 Mil) to Dec. 2024 ($6 Mil) but then increased from Dec. 2024 ($6 Mil) to Dec. 2025 ($441 Mil).


Imerys  (OTCPK:IMYSF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Imerys Marketable Securities Related Terms


Imerys Marketable Securities Historical Data

* Premium members only.

The historical data trend for Imerys's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imerys Marketable Securities Chart

Imerys Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.04 2.12 734.57 5.65 440.87

Imerys Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 734.57 604.20 5.65 7.38 440.87
IMYSF
59GF Score
Imerys IMYSF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imerys Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $441 Mil mean?
Imerys (IMYSF) has a Marketable Securities of $441 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Imerys and its competitors.
Is Imerys' Marketable Securities too high?
Imerys' current Marketable Securities is $441 Mil. Overall, Imerys has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imerys' Marketable Securities compare to LIN and SHW?
Imerys' Marketable Securities of $441 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Imerys and its competitors. Imerys's current Marketable Securities is $441 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imerys stock overvalued right now?
Based on GuruFocus' analysis, Imerys (IMYSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.72, compared to a current price of $24.72 — trading 22.1% below its estimated fair value. The current Marketable Securities is $441 Mil. Imerys' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Imerys (IMYSF), the current Marketable Securities is $441 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imerys (IMYSF) Overvalued in 2026?

Based on GuruFocus' analysis, Imerys stock appears to be undervalued. The current stock price of $24.72 is trading 22.1% below its estimated GF Value™ of $31.72. GuruFocus considers Imerys to be Modestly Undervalued.

Key valuation signals for IMYSF:

  • Marketable Securities: $441 Mil
  • GF Value™: $31.72 vs. price of $24.72 (22.1% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the IMYSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Imerys Business Description

Address 43 quai de Grenelle, Paris, FRA, 75015
Imerys manufactures and sells mineral-based specialty applications for multiple industries, including construction, renovation, iron and steel, and automotive. The company is organized into three activities: Performance Minerals comprises three geographic business areas - Europe, the Middle East and Africa, the Americas, and the Asia Pacific. It mainly serves the plastics, rubber, paints & coatings, filtration, renewable energy, and paper & board markets. The company operates in three segments: Performance Minerals, Refractory, Abrasives & Construction, and Solutions for Energy Transition. The majority of the revenue is generated from the Performance Minerals segment.
59GF Score

Get the complete analysis for IMYSF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.72
Price
$31.72
GF Value